Materials and Methods (The value of circulating microRNAs for early diagnosis of B-cell lymphoma: A case-control study on historical samples) v2 (protocols.io.rhid34e)

protocols.io ◽  
2018 ◽  
Author(s):  
Steffen J ◽  
Isabella Worlewenut ◽  
Jakob Werner ◽  
Dorte Tholstrup ◽  
Christoffer Hother ◽  
...  
Keyword(s):  
Early Diagnosis ◽  
B Cell ◽  
Case Control Study ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Case Control ◽  
Circulating Micrornas ◽  
Control Study ◽  
Historical Samples

scholarly journals The value of circulating microRNAs for early diagnosis of B-cell lymphoma: A case-control study on historical samples

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Steffen Jørgensen ◽  
Isabella Worlewenut Paulsen ◽  
Jakob Werner Hansen ◽  
Dorte Tholstrup ◽  
Christoffer Hother ◽  
...  
Keyword(s):  
Early Diagnosis ◽  
B Cell ◽  
Case Control Study ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Case Control ◽  
Circulating Micrornas ◽  
Control Study ◽  
Historical Samples

scholarly journals Prevalence of Anti-Citrullinated Protein Antibodies (ACPA) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL): A Case-Control Study

PLoS ONE ◽  
2014 ◽  
Vol 9 (2) ◽  
pp. e88177 ◽  
Author(s):  
Gunter Assmann ◽  
Klara Shihadeh ◽  
Viola Poeschel ◽  
Niels Murawski ◽  
Jutta Conigliarou ◽  
...  
Keyword(s):  
B Cell ◽  
Case Control Study ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Case Control ◽  
Large B Cell Lymphoma ◽  
Citrullinated Protein ◽  
Control Study ◽  
Large B Cell

scholarly journals Pretreatment circulating serum cytokines associated with follicular and diffuse large B-cell lymphoma: A clinic-based case-control study

Cytokine ◽  
2012 ◽  
Vol 60 (3) ◽  
pp. 882-889 ◽  
Author(s):  
Bridget Charbonneau ◽  
Matthew J. Maurer ◽  
Stephen M. Ansell ◽  
Susan L. Slager ◽  
Zachary S. Fredericksen ◽  
...  
Keyword(s):  
B Cell ◽  
Case Control Study ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Case Control ◽  
Serum Cytokines ◽  
Large B Cell Lymphoma ◽  
Control Study ◽  
Large B Cell

scholarly journals Multicentre Hospital-based Case-control Study of Diffuse Large B-cell Lymphoma in Shanghai, China

2012 ◽  
Vol 13 (7) ◽  
pp. 3329-3334 ◽  
Author(s):  
Rong Fan ◽  
Lu-Yao Zhang ◽  
Hong Wang ◽  
Bo Yang ◽  
Tao Han ◽  
...  
Keyword(s):  
B Cell ◽  
Case Control Study ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Case Control ◽  
Large B Cell Lymphoma ◽  
Control Study ◽  
Large B Cell

Clinicopathologic characteristics and outcomes of transformed diffuse large B-cell lymphoma in hepatitis C virus-infected patients: A case-control study of 84 patients.

2017 ◽  
Vol 35 (15_suppl) ◽  
pp. 7553-7553
Author(s):  
Jeff Hosry ◽  
Roberto N. Miranda ◽  
Francesco Turturro ◽  
Minas P. Economides ◽  
Felipe Samaniego ◽  
...  
Keyword(s):  
B Cells ◽  
B Cell ◽  
Case Control Study ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Cell Phenotype ◽  
First Line ◽  
Clinicopathologic Characteristics ◽  
Large B Cell Lymphoma ◽  
Control Study

7553 Background: Chronic hepatitis C virus (HCV) infection is associated with development of marginal zone lymphoma (MZL) and diffuse large B-cell lymphoma (DLBCL). Preliminary data showed particular characteristics of HCV-associated DLBCL; such as frequent transformation from indolent lymphomas and aggressive oncologic courses. We studied herein the clinicopathologic characteristics and outcomes of HCV-infected patients (pts) with transformed DLBCL. Methods: In this case control study, the medical records and pathology reports of HCV-infected (cases) and HCV-uninfected (controls) pts with transformed DLBCL seen at our institution (6/2004 - 5/2015) were reviewed. Included pts had a concomitant or a history of a low grade lymphoma. To determine their clinicopathologic characteristics, cases were compared to controls at a ratio of 1:3. To determine predictors of oncologic relapse, we compared pts with DLBCL relapse after first line chemotherapy to those who did not relapse in univariate and logistic regression analyses. Results: Twenty-one cases were compared to 63 controls. Compared to controls, cases were younger (median year age [interquartile range], 54 [49-62] v 62 [53-66], P = .01), had advanced Ann Arbor stages, 3-4 (95% v 76%, P = .05), and upper gastro-intestinal involvement (48% v 25%, P = .05). Immunophenotypically, cases had more CD10-negative B-cells (76% v 43%, P = .008) and CD5-positive B-cells (39% v 7%, P = .004) compared to controls, consistent with an activated B-cell phenotype. A comparison between pts who relapsed after first line chemotherapy (n = 42) and those who did not (n = 40) revealed that having CD5-positive B-cells was the only factor associated with DLBCL relapse in univariate (24% v 6%, P = .03) and multivariate analyses (OR = 10.7, P= .02). Conclusions: HCV-infected pts with transformed DLBCL are younger, present with advanced stages, are more commonly CD5-positive, and have an activated B-cell phenotype, suggesting more frequent transformation from MZL compared to HCV-uninfected pts. The higher frequency of CD5-positive B-cells might explain the higher DLBCL relapses previously described in HCV-infected pts.

Hepatitis C virus and GBV-C virus prevalence among patients with B-cell lymphoma in different European regions: a case-control study of the International Extranodal Lymphoma Study Group

2011 ◽  
Vol 30 (3) ◽  
pp. 137-142 ◽  
Author(s):  
Sabrina Nicolosi Guidicelli ◽  
Armando Lopez-Guillermo ◽  
Umberto Falcone ◽  
Annarita Conconi ◽  
Alexandre Christinat ◽  
...  
Keyword(s):  
Hepatitis C ◽  
Case Control Study ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Case Control ◽  
Study Group ◽  
European Regions ◽  
Virus Prevalence ◽  
Lymphoma Study Group ◽  
Control Study
Sign in / Sign up

Export Citation Format

Share Document